Matthew Brams
Vermögen: 33 933 $ am 31.05.2026
Vermögen: 33 933 $ am 31.05.2026
Matthew N.
Brams is the founder of Cingulate, Inc., founded in 2012, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is the founder of Cingulate Works, Inc., founded in 2013, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is also the founder of Cingulate Therapeutics LLC..
Dr. Brams is currently Clinical Associate Professor at Baylor College of Medicine.
Formerly, Medical Director & Principal at Bayou City Research, Inc. from 1999 to 2021.
Education includes undergraduate degree from The University of Texas at Austin and doctorate from The University of Texas Health Science Center at Houston.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CINGULATE, INC. 0,06 % | 18.05.2026 | 8 157 ( 0,06 % ) | 33 933 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CINGULATE INC. | Gründer | 01.05.2012 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Gründer | - |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Gründer | 01.01.2013 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Bayou City Research, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bayou City Research, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen